Doctor profile · Federal record
Dr. Macey Delcambre, M.D.
Dermatology Physician (CMS: Dermatology) · Austin, TX
- NPI 1033484415
- Accepts Medicare
- MIPS 98.3 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8825 Bee Caves RD Ste 100
Austin, TX 78746
(512) 328-3376
fax (512) 540-5706
Credentials & registration
- NPI registered
- March 2012 — 14 yrs on file
- Profile last updated
- February 6, 2019
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #R6771
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1033484415. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,263
Distinct HCPCS
10
Medicare allowed
$129,884
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 853 | 150 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 592 | 381 | $90 | |
17000 |
Destruction of precancer skin growth, 1 growth | 281 | 204 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 226 | 190 | $101 | |
17110 |
Destruction of skin growth, 1-14 growths | 66 | 57 | $114 | |
11103 |
Biopsy of related skin growth, each additional growth | 60 | 43 | $52 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 57 | 51 | $56 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 35 | 35 | $113 | |
17261 |
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 30 | 28 | $132 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 18 | 17 | $169 |
In context: peer comparison
Among 36 peers in Austin Dermatology Physician, average services per provider: 188. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,540
Transactions
77
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 19 | $314.21 | |
| Abbvie INC. | 19 | $307.30 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $225.76 | |
| Genzyme Corporation | 7 | $147.94 | |
| Sanofi-Aventis U.S. LLC | 1 | $94.99 | |
| Arcutis Biotherapeutics, INC. | 4 | $94.34 | |
| Leo Pharma INC. | 4 | $71.40 | |
| Sun Pharmaceutical Industries INC. | 3 | $48.36 | |
| Lilly USA, LLC | 2 | $45.02 | |
| Regeneron Healthcare Solutions, INC. | 2 | $42.33 | |
| Ucb, INC. | 2 | $37.25 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $23.27 | |
| Biofrontera INC. | 1 | $21.52 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $18.13 | |
| Pfizer INC. | 1 | $17.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
230
Patients
78
Total drug cost
$71,281
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 43 | 16 | $1,309 |
| Triamcinolone Acetonide | Generic | 40 | 34 | $364 |
| Minoxidil | Generic | 32 | 0 | $242 |
| Ketoconazole | Generic | 28 | 0 | $552 |
| Clobetasol Propionate | Generic | 25 | 15 | $1,649 |
| Clindamycin Phosphate | Generic | 23 | 0 | $758 |
| Mupirocin | Generic | 14 | 13 | $141 |
| Dupixent Pen (Dupilumab) | Brand | 13 | 0 | $50,338 |
| Vtama (Tapinarof) | Brand | 12 | 0 | $15,927 |
Frequently asked questions
What is Dr. Macey Delcambre's medical specialty?
Dr. Macey Delcambre practices Dermatology Physician in Austin, TX.
Where does Dr. Macey Delcambre practice?
Dr. Macey Delcambre practices at 8825 Bee Caves RD Ste 100, Austin, TX 78746. Office phone: 5123283376.
What is Dr. Macey Delcambre's NPI?
Dr. Macey Delcambre's National Provider Identifier (NPI) is 1033484415, issued by NPPES.
Does Dr. Macey Delcambre accept Medicare assignment?
Yes. Dr. Macey Delcambre accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Macey Delcambre commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.